(Q36719871)

15 August 2017

1 reference

title

Medications in the treatment of borderline personality disorder 2006. (English)

1 reference

borderline personality disorder

15 August 2017

main subject

0 references

author name string

Deanna Mercer

series ordinal

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 February 2007

1 reference

Current Psychiatry Reports

15 August 2017

published in

1 reference

15 August 2017

volume

9

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

53-62

1 reference

Fluoxetine in the treatment of borderline and schizotypal personality disorders

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0010-1

Fluoxetine and impulsive aggressive behavior in personality-disordered subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0010-1

Efficacy of phenelzine and haloperidol in borderline personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0010-1

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0010-1

Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0010-1

Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0010-1

Lithium Carbonate in Emotionally Unstable Character Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0010-1

Cognitive-Behavioral Treatment of Chronically Parasuicidal Borderline Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0010-1

Lamotrigine as a promising approach to borderline personality: an open case series without concurrent DSM-IV major mood disorder

21 January 2018

1 reference

12 December 2020

Quetiapine in the treatment of borderline personality disorder

1 reference

12 December 2020

SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder

1 reference

12 December 2020

Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study.

1 reference

12 December 2020

A preliminary trial of fluoxetine in refractory borderline patients.

1 reference

12 December 2020

Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol

1 reference

12 December 2020

Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

1 reference

12 December 2020

Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours

1 reference

12 December 2020

Predictors of benzodiazepine discontinuation in subjects manifesting complicated dependence

1 reference

12 December 2020

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

1 reference

12 December 2020

Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study

1 reference

12 December 2020

Naloxone in the treatment of acute dissociative states in female patients with borderline personality disorder.

1 reference

12 December 2020

Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder.

1 reference

12 December 2020

Oxcarbazepine in the treatment of borderline personality disorder: a pilot study

1 reference

12 December 2020

Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.

1 reference

12 December 2020

Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia.

1 reference

12 December 2020

Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.

1 reference

12 December 2020

Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type under treatment with clozapine

1 reference

12 December 2020

Naltrexone as a treatment of self-injurious behavior--a case report

1 reference

12 December 2020

Venlafaxine in the treatment of borderline personality disorder

1 reference

12 December 2020

A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.

1 reference

12 December 2020

Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association

1 reference

12 December 2020

Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.

1 reference

12 December 2020

Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder

1 reference

12 December 2020

Divalproex in the Treatment of Impulsive Aggression: Efficacy in Cluster B Personality Disorders

1 reference

12 December 2020

A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.

1 reference

12 December 2020

Two-Year Randomized Controlled Trial and Follow-up of Dialectical Behavior Therapy vs Therapy by Experts for Suicidal Behaviors and Borderline Personality Disorder

1 reference

12 December 2020

Borderline personality disorder in major depression: symptomatology, temperament, character, differential drug response, and 6-month outcome

1 reference

12 December 2020

Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder

1 reference

12 December 2020

A trial of carbamazepine in borderline personality disorder.

1 reference

12 December 2020

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

1 reference

12 December 2020

The positive effect of alprazolam in the treatment of three patients with borderline personality disorder

1 reference

12 December 2020

Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services

1 reference

12 December 2020

Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study

1 reference

12 December 2020

Injectable Atypical Antipsychotics for Agitation in Borderline Personality Disorder

1 reference

12 December 2020

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Dialectical behaviour therapy for women with borderline personality disorder: 12-month, randomised clinical trial in The Netherlands

1 reference

12 December 2020

Effects of naloxone and naltrexone on self-injury: a double-blind, placebo-controlled analysis.

1 reference

12 December 2020

Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Naltrexone decreases self-injurious behavior

1 reference

12 December 2020

Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up

1 reference

12 December 2020

Treatment of borderline personality disorder with risperidone

1 reference

12 December 2020

Worsening of borderline symptoms under reboxetine treatment

1 reference

12 December 2020

Pharmacological prevention of suicidal behaviour

1 reference

12 December 2020

Fluoxetine in borderline personality disorder

1 reference

12 December 2020

Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients

1 reference

12 December 2020

Naltrexone treatment of self-injurious thoughts and behaviors

1 reference

12 December 2020

Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder

1 reference

12 December 2020

Treatment histories of borderline inpatients

1 reference

12 December 2020

Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression

1 reference

12 December 2020

Low-Dose Clozapine in Acute and Continuation Treatment of Severe Borderline Personality Disorder

1 reference

12 December 2020

Combined treatment of major depression in patients with borderline personality disorder: a comparison with pharmacotherapy

1 reference

12 December 2020

Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder

1 reference

12 December 2020

Clozapine treatment of borderline patients: a preliminary study

1 reference

12 December 2020

Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder.

1 reference

12 December 2020

Topiramate for self-mutilation in a patient with borderline personality disorder

1 reference

12 December 2020

Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence

1 reference

12 December 2020

Olanzapine versus placebo in the treatment of borderline personality disorder

1 reference

12 December 2020

Response of borderline patients to loxapine and chlorpromazine

1 reference

12 December 2020

Remission of self-mutilation in a patient with borderline personality during risperidone therapy

1 reference

12 December 2020

10.1007/S11920-007-0010-1

Identifiers

DOI

1 reference

15 August 2017

1 reference